TOX3 and breast carcinoma: Our data also showed a 2.93±0.27 fold increase in TOX3 expression in 5-aza-CdR treated cells compared to control, indicating that CpG methylation of the TOX3 promoter plays a significant role in the regulation of TOX3 expression in the breast cancer cell line.